These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9217665)

  • 1. High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener's granulomatosis.
    Wang G; Hansen H; Tatsis E; Csernok E; Lemke H; Gross WL
    Am J Med; 1997 Jun; 102(6):517-23. PubMed ID: 9217665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides.
    Schönermarck U; Csernok E; Trabandt A; Hansen H; Gross WL
    Clin Exp Rheumatol; 2000; 18(4):457-63. PubMed ID: 10949720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity.
    Schmitt WH; Heesen C; Csernok E; Rautmann A; Gross WL
    Arthritis Rheum; 1992 Sep; 35(9):1088-96. PubMed ID: 1418025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of soluble CD30 in cord blood and peripheral blood during childhood are not correlated with the development of atopic disease or a family history of atopy.
    Holmlund U; Bengtsson A; Nilsson C; Kusoffsky E; Lilja G; Scheynius A; Sverremark-Ekström E
    Clin Exp Allergy; 2003 Nov; 33(11):1531-6. PubMed ID: 14616865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum markers of T cell activation in relapses of Wegener's granulomatosis.
    Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
    Clin Exp Immunol; 1993 Mar; 91(3):415-20. PubMed ID: 8443965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
    van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
    Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble CD26 and CD30 and their clinical significance in patients with rheumatoid arthritis.
    Ulusoy H; Kamanli A; Ilhan N; Kuru O; Arslan S; Alkan G; Ozgocmen S
    Rheumatol Int; 2012 Dec; 32(12):3857-62. PubMed ID: 22193227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
    Moosig F; Csernok E; Wang G; Gross WL
    Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD30 in early rheumatoid arthritis as a predictor of good response to second-line therapy.
    Gerli R; Bistoni O; Lunardi C; Giacomelli R; Tomassini C; Biagini P; Pitzalis C
    Rheumatology (Oxford); 1999 Dec; 38(12):1282-4. PubMed ID: 10587561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
    Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
    J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role.
    Gerli R; Pitzalis C; Bistoni O; Falini B; Costantini V; Russano A; Lunardi C
    J Immunol; 2000 Apr; 164(8):4399-407. PubMed ID: 10754341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.
    Lamprecht P; Moosig F; Gause A; Herlyn K; Csernok E; Hansen H; Gross WL
    Ann Rheum Dis; 2001 Apr; 60(4):385-90. PubMed ID: 11247870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of soluble CD30 in chronic hepatitis B virus infection.
    Fattovich G; Vinante F; Giustina G; Morosato L; Alberti A; Ruol A; Pizzolo G
    Clin Exp Immunol; 1996 Jan; 103(1):105-10. PubMed ID: 8565268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
    Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
    Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-soluble CD30 in childhood tuberculosis: effects of disease severity, nutritional status, and vitamin A therapy.
    Hanekom WA; Hussey GD; Hughes EJ; Potgieter S; Yogev R; Check IJ
    Clin Diagn Lab Immunol; 1999 Mar; 6(2):204-8. PubMed ID: 10066655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).
    Brouwer E; Stegeman CA; Huitema MG; Limburg PC; Kallenberg CG
    Clin Exp Immunol; 1994 Dec; 98(3):448-53. PubMed ID: 7994909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte activation in patients with Wegener's granulomatosis.
    Muller Kobold AC; Kallenberg CG; Tervaert JW
    Ann Rheum Dis; 1999 Apr; 58(4):237-45. PubMed ID: 10364903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis.
    Abdulahad WH; van der Geld YM; Stegeman CA; Kallenberg CG
    Kidney Int; 2006 Sep; 70(5):938-47. PubMed ID: 16837919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-helper 2 involvement in the pathogenesis of bullous pemphigoid: role of soluble CD30 (sCD30).
    De Pitá O; Frezzolini A; Cianchini G; Ruffelli M; Teofoli P; Puddu P
    Arch Dermatol Res; 1997 Nov; 289(12):667-70. PubMed ID: 9452886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.